President and CEO
Michael Christman, Ph.D., is president and chief executive officer of the Coriell Institute for Medical Research. In 2007, Dr. Christman initiated the Coriell Personalized Medicine Collaborative (CPMC), a research study evaluating the utility of using the knowledge of genetics in medicine. Under Dr. Christmans leadership, Coriell has also established a federally-funded Induced Pluripotent Stem Cell lab. This remarkable technology allows a skin or blood cell to be coaxed into becoming nearly any cell type in the body, opening new avenues for research, drug discovery, and eventually therapy.